{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:14:36Z","timestamp":1789024476699,"version":"build-2803163510"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000601","name":"De Montfort University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","award":["DE-AC02-05CH11231"],"award-info":[{"award-number":["DE-AC02-05CH11231"]}],"id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006151","name":"Basic Energy Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000857","name":"Loughborough University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.bmcl.2024.129825","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T05:57:25Z","timestamp":1717135045000},"page":"129825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Novel 4-[4-(4-methylpiperazin-1-yl)phenyl]-6-arylpyrimidine derivatives and their antitrypanosomal activities against T.brucei"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3381-592X","authenticated-orcid":false,"given":"Annie E.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Hering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.J.","family":"Elsegood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Teat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1316-1941","authenticated-orcid":false,"given":"George W.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randolph R.J.","family":"Arroo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Maeser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7673-4797","authenticated-orcid":false,"given":"Avninder S.","family":"Bhambra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2024.129825_b0005","unstructured":"dndi.org. (2022). Neglected Tropical Diseases (NTDs) | DNDi. [online] Available at: https:\/\/dndi.org\/diseases\/neglected-tropical-diseases\/."},{"key":"10.1016\/j.bmcl.2024.129825_b0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41579-022-00797-8","article-title":"Anti-trypanosomatid drug discovery: progress and challenges","author":"De Rycker","year":"2022","journal-title":"Nature Rev Microbiol"},{"key":"10.1016\/j.bmcl.2024.129825_b0015","doi-asserted-by":"crossref","unstructured":"Cleghorn, L.A.T., Wall, R.J., Albrecht, S., MacGowan, S.A., Norval, S., Manu De Rycker, Woodland, A., Spinks, D., Thompson, S., Patterson, S., Victoriano Corpas Lopez, Dey, G., Collie, I.T., Hallyburton, I., Kime, R., Simeons, F.R.C., Stojanovski, L., Frearson, J.A., Wyatt, P.G. and Read, K.D. (2023). Development of a 2,4-Diaminothiazole Series for the Treatment of Human African Trypanosomiasis Highlights the Importance of Static\u2013Cidal Screening of Analogues. doi:https:\/\/doi.org\/10.1021\/acs.jmedchem.3c00509.","DOI":"10.1021\/acs.jmedchem.3c00509"},{"key":"10.1016\/j.bmcl.2024.129825_b0020","unstructured":"www.who.int. (n.d.).Trypanosomiasis, human African (sleeping sickness). [online] Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/trypanosomiasis-human-african-(sleeping-sickness)#:\u223c:text=Human%20African%20trypanosomiasis%2C%20also%20known."},{"key":"10.1016\/j.bmcl.2024.129825_b0025","doi-asserted-by":"crossref","first-page":"e0010155","DOI":"10.1371\/journal.pntd.0010155","article-title":"The effect of livestock density on Trypanosoma brucei gambiense and T. b. rhodesiense: A causal inference-based approach","volume":"16","author":"Meisner","year":"2022","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"10.1016\/j.bmcl.2024.129825_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112871","article-title":"The discovery of novel antitrypanosomal 4-phenyl-6-(pyridin-3-yl) pyrimidines","volume":"209","author":"Robinson","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129825_b0035","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejmech.2015.11.043","article-title":"Design, synthesis and antitrypanosomal activities of 2,6-disubstituted-4,5,7-trifluorobenzothiophenes","volume":"108","author":"Bhambra","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129825_b0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejmech.2017.01.027","article-title":"Synthesis and antitrypanosomal activities of novel pyridylchalcones","volume":"128","author":"Bhambra","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129825_b0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053273314026370","article-title":"SHELXT\u2013 Integrated space-group and crystal-structure determination","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallographica Section A Found Adv"},{"key":"10.1016\/j.bmcl.2024.129825_b0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallographica Section C Struct Chem"},{"key":"10.1016\/j.bmcl.2024.129825_b0055","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cmdc.201900544","article-title":"Structure\u2212activity relationships of cinnamate ester analogues as potent antiprotozoal agents","volume":"15","author":"Bernal","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmcl.2024.129825_b0060","unstructured":"EMA (2021). Fexinidazole Winthrop. [online] European Medicines Agency. Available at: https:\/\/www.ema.europa.eu\/en\/opinion-medicine-use-outside-EU\/human\/fexinidazole-winthrop."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24002270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24002270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T13:42:44Z","timestamp":1719668564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X24002270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":12,"alternative-id":["S0960894X24002270"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129825","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel 4-[4-(4-methylpiperazin-1-yl)phenyl]-6-arylpyrimidine derivatives and their antitrypanosomal activities against T.brucei","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129825","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129825"}}